HEARTBEAM, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 35.00K shares, a 2307.15% increase year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 7.71K shares, a 92.75% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 21.82K shares, a 33.52% decline year-over-year.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 89.78K shares, a 37.83% decline from fiscal 2024.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 144.41K shares, a 19.81% decline from fiscal 2023.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 180.07K shares, a 364.03% increase from fiscal 2022.
- HEARTBEAM, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 38.81K shares, a 11.36% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 35.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | 64.53K shares derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-13 | 30.98K shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 7.71K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 89.78K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 21.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 188.41K shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | 1.45K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 199.41K shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | 58.80K shares 10-Q · filed 2025-05-13 | 203.21K shares derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | 106.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 144.41K shares 10-K · filed 2026-03-12 |
| 2024-09-30 | 32.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -69.86K shares derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-06-30 | 5.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 97.30K shares derived: sum of 4 quarters · filed 2025-03-13 |
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-09 | 180.07K shares derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-12-31 | -107.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 180.07K shares 10-K · filed 2025-03-13 |
| 2023-09-30 | 199.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | 293.12K shares derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-06-30 | 88.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | 98.26K shares derived: sum of 4 quarters · filed 2024-03-20 |
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-11 | 29.61K shares derived: sum of 4 quarters · filed 2024-03-20 |
| 2022-12-31 | 5.12K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 38.81K shares 10-K · filed 2024-03-20 |
| 2022-09-30 | 5.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | 41.07K shares derived: sum of 4 quarters · filed 2023-03-16 |
| 2022-06-30 | 19.37K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | |
| 2022-03-31 | 9.20K shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 7.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 34.85K shares 10-K · filed 2023-03-16 |
| 2020-12-31 | 10.80K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | 45.00K shares 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |